Hematology and Oncology

Research output

Research output per year 1988 2015 2016 2017 2018 2022

• 55 Article
• 9 Review article
• 4 Comment/debate
• 1 Conference contribution
• 2 More
  • 1 Letter
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2022

  Insights into Clinical Features and Outcomes of Adrenal Cortical Carcinosarcoma

  Branham, Z., Fox, A. D., Ullah, A., Patel, N. G., Terris, M. & Parikh, J., Oct 2022, In: Diagnostics. 12, 10, 2419.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Retroperitoneal 100%
  • Carcinosarcoma 70%
  • Psoas Muscles 36%
  • Adrenocortical Carcinoma 17%
  • Inhibins 17%
• 2021

  Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations

  Kidwell, K., Albo, C., Pope, M., Bowman, L., Xu, H., Wells, L., Barrett, N., Patel, N., Allison, A. & Kutlar, A., Feb 2021, In: PloS one. 16, 2 February, e0247324.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Sickle Cell Anemia 100%
  • Hospital Emergency Service 88%
  • Hospitalization 81%
  • Anxiety 26%
  • Depression 24%
  4 Scopus citations

• DIAPH1 Mutation as a Novel Cause of Autosomal Dominant Macrothrombocytopenia and Hearing Loss

  Karki, N. R., Ajebo, G. H., Savage, N. & Kutlar, A., Jan 2021, In: Acta Haematologica. 144, 1, p. 91-94 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Hearing Loss 100%
  • Blood Platelets 81%
  • Gain of Function Mutation 69%
  • Hemorrhage 67%
  • Idiopathic Thrombocytopenic Purpura 62%
  4 Scopus citations

• Meta-analysis of gastrointestinal adverse events from tyrosine kinase inhibitors for chronic myeloid leukemia

  Mohanavelu, P., Mutnick, M., Mehra, N., White, B., Kudrimoti, S., Hernandez Kluesner, K., Chen, X., Nguyen, T., Horlander, E., Thenot, H., Kota, V. & Mitchell, C. S., Apr 1 2021, In: Cancers. 13, 7, 1643.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 100%
  • Protein-Tyrosine Kinases 86%
  • bosutinib 79%
  • Meta-Analysis 71%
  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 51%
  14 Scopus citations

• Skene's Gland Adenocarcinoma: Borrowing From Prostate Cancer Experience for the Evaluation and Management of a Rare Malignancy

  Kaufman, M. E., Miller, D. T., Ullah, A., White, J., Singh, G., Kolhe, R., Williams, H., Mittal, P., Parikh, J. & Terris, M. K., May 2021, In: Urology. 151, p. 182-187 6 p.

  Research output: Contribution to journal › Article › peer-review

  • fluciclovine F-18 100%
  • Multiparametric Magnetic Resonance Imaging 75%
  • Prostatic Neoplasms 63%
  • Adenocarcinoma 63%
  • Prostate-Specific Antigen 54%
  5 Scopus citations
• 2020

  Association between PD-L1 status and immune checkpoint inhibitor response in advanced malignancies: A systematic review and meta-analysis of overall survival data

  Wallis, C. J. D., Lawson, K., Butaney, M., Satkunasivam, R., Parikh, J., Freedland, S. J., Patel, S. P., Hamid, O., Pal, S. K. & Klaassen, Z., Jul 1 2020, In: Japanese Journal of Clinical Oncology. 50, 7, p. 800-809 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Meta-Analysis 100%
  • Systematic Reviews 98%
  • Ligands 94%
  • Survival 74%
  • Immunotherapy 73%
  10 Scopus citations

• Characteristics and potential biomarkers of adult sickle cell patients with chronic pain

  Albo, C., Kumar, S., Pope, M., Kidwell, K. M., Xu, H., Bowman, L., Wells, L., Barrett, N., Fields, S., Bora, P., Patel, N. & Kutlar, A., Oct 1 2020, In: European Journal of Haematology. 105, 4, p. 419-425 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Pain 100%
  • Biomarkers 71%
  • Opioid Analgesics 54%
  • Nerve Growth Factor 39%
  • Neurogenic Inflammation 17%
  6 Scopus citations

• Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

  Gwynn, M. E., DeRemer, D. L., Saunders, K. M., Parikh, J., Bollag, R. J. & Clemmons, A. B., Apr 1 2020, In: Journal of Oncology Pharmacy Practice. 26, 3, p. 647-654 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Influenza Vaccines 100%
  • Human Influenza 72%
  • Vaccination 56%
  • Neoplasms 28%
  • Chemokines 24%
  19 Scopus citations

• Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease

  Mangaonkar, A. A., Thawer, F., Son, J., Ajebo, G., Xu, H., Barrett, N. J., Wells, L. G., Bowman, L., Clair, B., Patel, N., Bora, P., Jung, G., Nemeth, E. & Kutlar, A., Jun 1 2020, In: British Journal of Haematology. 189, 6, p. 1204-1209 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hepcidins 100%
  • Sickle Cell Anemia 82%
  • Iron Overload 69%
  • Iron 62%
  • Homeostasis 55%
  11 Scopus citations
• 2019

  Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation

  Clemmons, A. B., Gandhi, A. S., Albrecht, B., Jacobson, S. & Pantin, J., Mar 1 2019, In: Journal of Oncology Pharmacy Practice. 25, 2, p. 326-332 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluoroquinolones 100%
  • Cell Transplantation 96%
  • Bacteremia 91%
  • Clostridium difficile 60%
  • Mortality 32%
  1 Scopus citations
• 2018

  Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime

  Clemmons, A. B., Bech, C. F., Pantin, J. & Ahmad, I., Apr 2018, In: Biology of Blood and Marrow Transplantation. 24, 4, p. 820-826 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cefepime 100%
  • Tazobactam Drug Combination Piperacillin 97%
  • Cell Transplantation 80%
  • Vancomycin 78%
  • Acute Kidney Injury 70%
  17 Scopus citations

• Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

  Tageja, N., Korde, N., Kazandjian, D., Panch, S., Manasanch, E., Bhutani, M., Kwok, M., Mailankody, S., Yuan, C., Stetler-Stevenson, M., Leitman, S. F., Sportes, C. & Landgren, O., Nov 1 2018, In: Bone marrow transplantation. 53, 11, p. 1445-1449 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • carfilzomib 100%
  • Lenalidomide 83%
  • Dexamethasone 57%
  • Residual Neoplasm 50%
  • Stem Cells 46%
  13 Scopus citations

• Metastatic breast cancer presenting as orbital mass: A case report with literature review

  Shaikh, R., Tariq, K., Sharma, S. & Tang, S-C., Mar 1 2018, In: Journal of Global Oncology. 2018, 4, p. 1-4 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients

  Ku, P. M., Waller, J. L., Sportès, C. & Clemmons, A. B., Aug 1 2018, In: Supportive Care in Cancer. 26, 8, p. 2809-2814 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Magnesium Sulfate 100%
  • Magnesium 77%
  • Intravenous Infusions 74%
  • Transplants 48%
  • Transplant Recipients 12%
  4 Scopus citations

• Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial

  Clemmons, A. B., Orr, J., Andrick, B., Gandhi, A., Sportes, C. & DeRemer, D., Oct 2018, In: Biology of Blood and Marrow Transplantation. 24, 10, p. 2065-2071 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • fosaprepitant 100%
  • Ondansetron 70%
  • Olanzapine 65%
  • Cell Transplantation 57%
  • Hematologic Neoplasms 54%
  30 Scopus citations

• Unfortunate accident or blessing in disguise? Dramatic response to incidental intrathoracic delivery of anti-HER2 regimen

  Tariq, K., Keen, R., Draper, K. & Tang, S. C., Mar 1 2018, In: Journal of Global Oncology. 2018, 4, p. 1-4 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
• 2017

  Allogeneic transplantation using CD34⁺ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia

  Purev, E., Tian, X., Aue, G., Pantin, J., Vo, P., Shalabi, R., Reger, R. N., Cook, L., Ramos, C., Cho, E., Worthy, T., Khuu, H., Stroncek, D., Young, N. S. & Childs, R. W., Mar 1 2017, In: British Journal of Haematology. 176, 6, p. 950-960 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Aplastic Anaemia 100%
  • Homologous Transplantation 93%
  • Graft vs Host Disease 87%
  • Blood Cells 68%
  • Tissue Donors 65%
  8 Scopus citations

• Anti-HER-2 therapy following severe trastuzumab-induced cardiac toxicity

  Sadek, I., Keaton, M., Maihle, N. J. & Tang, S. C., Sep 1 2017, In: Genes and Diseases. 4, 3, p. 159-162 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • human ERBB2 protein 100%
  • Trastuzumab 96%
  • Cardiotoxicity 92%
  • Thoracic Wall 32%
  • Breast Neoplasms 26%
  3 Scopus citations

• Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: Updated results from a phase 1/2 open-label study

  Powles, T., O'Donnell, P. H., Massard, C., Arkenau, H. T., Friedlander, T. W., Hoimes, C. J., Lee, J. L., Ong, M., Sridhar, S. S., Vogelzang, N. J., Fishman, M. N., Zhang, J., Srinivas, S., Parikh, J., Antal, J., Jin, X., Gupta, A. K., Ben, Y. & Hahn, N. M., Sep 2017, In: JAMA Oncology. 3, 9, e172411.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • durvalumab 100%
  • Carcinoma 38%
  • Safety 33%
  • Ligands 7%
  • Response Evaluation Criteria in Solid Tumors 6%
  717 Scopus citations

• Label-free ferrohydrodynamic cell separation of circulating tumor cells

  Zhao, W., Cheng, R., Jenkins, B. D., Zhu, T., Okonkwo, N. E., Jones, C. E., Davis, M. B., Kavuri, S. K., Hao, Z., Schroeder, C. & Mao, L., Sep 21 2017, In: Lab on a Chip. 17, 18, p. 3097-3111 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ferrofluid 100%
  • Circulating Neoplastic Cells 88%
  • Cell Separation 84%
  • Tumors 72%
  • Cells 69%
  53 Scopus citations

• Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition

  Sodji, Q., Klein, K., Sravan, K. & Parikh, J. R., Aug 15 2017, In: Journal for ImmunoTherapy of Cancer. 5, 1, 62.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Medullary Carcinoma 100%
  • Nivolumab 60%
  • Ligands 50%
  • Kidney 37%
  • Mortality 17%
  24 Scopus citations

• Promoter methylation modulates indoleamine 2,3-dioxygenase 1 induction by activated T cells in human breast cancers

  Noonepalle, S. K., Gu, F., Lee, E. J., Choi, J. H., Han, Q., Kim, J., Ouzounova, M., Shull, A. Y., Pei, L., Hsu, P. Y., Kolhe, R., Shi, F., Choi, J., Chiou, K., Huang, T. H. M., Korkaya, H., Deng, L., Xin, H. B., Huang, S., Thangaraju, M., & 5 othersSreekumar, A., Ambs, S., Tang, S. C., Munn, D. H. & Shi, H., Apr 2017, In: Cancer Immunology Research. 5, 4, p. 330-344 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Indoleamine-Pyrrole 2,3,-Dioxygenase 100%
  • Methylation 66%
  • Breast Neoplasms 47%
  • T-Lymphocytes 45%
  • Triple Negative Breast Neoplasms 44%
  27 Scopus citations

• Receptor Tyrosine Kinases in Human Platelets: A Review of Expression, Function and Inhibition in Relation to the Risk of Bleeding or Thrombocytopenia from Phase I through Phase III Trials

  Abdul Sater, H., Gandhi, A. S., Dainer, P. M. & Pantin, J. M., 2017, In: Journal of Cancer Prevention & Current Research. 8, 6

  Research output: Contribution to journal › Article › peer-review
• 2016

  Battling regional (stage III) lung cancer: Bumpy road of a cancer survivor in the immunotherapy age

  Hao, Z., Biddinger, P., Schroeder, C. & Tariq, K., 2016, In: BMJ Case Reports. 2016, 215304.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Nivolumab 100%
  • Cancer Survivors 80%
  • Immunotherapy 64%
  • durvalumab 63%
  • ramucirumab 59%
  2 Scopus citations

• Immunotherapy for breast cancer: past, present, and future

  Spellman, A. & Tang, S. C., Dec 1 2016, In: Cancer and Metastasis Reviews. 35, 4, p. 525-546 22 p.

  Research output: Contribution to journal › Article › peer-review

  • Immunotherapy 100%
  • Breast Neoplasms 72%
  • Bispecific Antibodies 26%
  • Immunoconjugates 25%
  • Tumor Microenvironment 19%
  33 Scopus citations

• Mutant KRAS conversion of conventional T cells into regulatory T cells

  Zdanov, S., Mandapathil, M., Eid, R. A., Adamson-Fadeyi, S., Wilson, W., Qian, J., Carnie, A., Tarasova, N., Mkrtichyan, M., Berzofsky, J. A., Whiteside, T. L. & Khleif, S. N., 2016, In: Cancer Immunology Research. 4, 4, p. 354-365 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Regulatory T-Lymphocytes 100%
  • T-Lymphocytes 62%
  • Oncogenes 34%
  • Neoplasms 32%
  • MAP Kinase Signaling System 10%
  106 Scopus citations

• Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed

  Eid, R. A., Razavi, G. S. E., Mkrtichyan, M., Janik, J. & Khleif, S. N., May 2016, In: Cancer Immunology Research. 4, 5, p. 377-382 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug Repositioning 100%
  • Tumor Microenvironment 45%
  • Costs and Cost Analysis 45%
  • Drug Therapy 42%
  • Cyclophosphamide 40%
  40 Scopus citations

• Progressing Preemptive Genotyping of CYP2C19 Allelic Variants for Sickle Cell Disease Patients

  Jaja, C., Barrett, N., Patel, N., Lyon, M., Xu, H. & Kutlar, A., Oct 1 2016, In: Genetic Testing and Molecular Biomarkers. 20, 10, p. 609-615 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytochrome P-450 CYP2C19 100%
  • Sickle Cell Anemia 82%
  • Alleles 22%
  • Pharmaceutical Preparations 18%
  • Phenotype 18%
  1 Scopus citations

• Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1

  Xie, X., Tang, S. C., Cai, Y., Pi, W., Deng, L., Wu, G., Chavanieu, A. & Teng, Y., 2016, In: Oncotarget. 7, 36, p. 58111-58120 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ADP-Ribosylation Factor 1 100%
  • Breast Neoplasms 37%
  • Neoplasm Metastasis 35%
  • Zebrafish 10%
  • Genes 8%
  35 Scopus citations

• The pretreatment neutrophil/lymphocyte ratio is associated with all-cause mortality in black and white patients with non-metastatic breast cancer

  Rimando, J., Campbell, J., Kim, J. H., Tang, S. C. & Kim, S., 2016, In: Frontiers in Oncology. 6, MAR, 81.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • European Continental Ancestry Group 100%
  • Neutrophils 84%
  • Lymphocytes 74%
  • Breast Neoplasms 68%
  • Mortality 54%
  15 Scopus citations

• YM155 inhibits topoisomerase function

  Hong, M., Ren, M. Q., Silva, J., Paul, A., Wilson, W. D., Schroeder, C., Weinberger, P., Janik, J. & Hao, Z., Oct 13 2016, In: Anti-Cancer Drugs. 28, 2, p. 142-152 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • YM 155 100%
  • DNA 83%
  • Intercalating Agents 79%
  • DNA Cleavage 66%
  • Circular Dichroism 61%
  18 Scopus citations
• 2015

  A new ªγ-globin chain variant: Hb F-Sykesville MD [ªγ113(G15)Val → Ile; HBG1: C.340G>A] detected in a caucasian baby

  Patel, N., Fixler, J., Unguru, Y., Kutlar, A. & Kutlar, F., Feb 1 2015, In: Hemoglobin. 39, 1, p. 52-54 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Val-Ile 100%
  • Fetal Hemoglobin 81%
  • Globins 77%
  • Hemoglobin 56%
  • A 113 33%
  1 Scopus citations

• Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor

  Vo, P. T., Pantin, J., Ramos, C., Cook, L., Cho, E., Kurlander, R., Khuu, H., Barrett, J., Leitman, S. & Childs, R. W., Jun 26 2015, In: Journal of Hematology and Oncology. 8, 1, 78.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Antilymphocyte Serum 100%
  • Aplastic Anaemia 95%
  • Monozygotic Twins 95%
  • Horses 75%
  • Tissue Donors 62%
  13 Scopus citations

• Fruit and vegetable intake and urinary levels of prostaglandin E₂ metabolite in postmenopausal women

  Kim, S., Rimando, J. & Sandler, D. P., May 19 2015, In: Nutrition and Cancer. 67, 4, p. 580-586 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Vegetables 100%
  • Dinoprostone 97%
  • Fruit 95%
  • Healthy Diet 38%
  • Nutrition Policy 21%
  3 Scopus citations

• Indomethacin induces apoptosis in the EC109 esophageal cancer cell line by releasing second mitochondria-derived activator of caspase and activating caspase-3

  Qin, S., Xu, C., Li, S., Yang, C., Sun, X., Wang, X., Tang, S. C. & Ren, H., Jun 1 2015, In: Molecular Medicine Reports. 11, 6, p. 4694-4700 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Nonsteroid Antiinflammatory Agent 100%
  • Esophageal Neoplasms 88%
  • Caspases 87%
  • Indomethacin 86%
  • Caspase 3 77%
  10 Scopus citations

• Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: Results from a prospective study of women with a sister with breast cancer

  Kim, S., Shore, D. L., Wilson, L. E., Sanniez, E. I., Kim, J. H., Taylor, J. A. & Sandler, D. P., Dec 16 2015, In: BMC Cancer. 15, 1, 960.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Inflammatory Breast Neoplasms 100%
  • Siblings 61%
  • Anti-Inflammatory Agents 49%
  • Breast Neoplasms 43%
  • Prospective Studies 43%
  44 Scopus citations

• Non-steroidal anti-inflammatory drug use and genomic DNA methylation in blood

  Wilson, L. E., Kim, S., Xu, Z., Harlid, S., Sandler, D. P. & Taylor, J. A., Sep 22 2015, In: PloS one. 10, 9, e0138920.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • nonsteroidal anti-inflammatory agents 100%
  • Nonsteroid Antiinflammatory Agent 86%
  • DNA methylation 79%
  • DNA Methylation 73%
  • Anti-Inflammatory Agents 55%
  8 Scopus citations

• Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management

  Jaja, C., Bowman, L., Wells, L., Patel, N., Xu, H., Lyon, M. & Kutlar, A., Aug 1 2015, In: Clinical and Translational Science. 8, 4, p. 272-280 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytochrome P-450 CYP2C8 100%
  • Cytochrome P-450 CYP2C9 86%
  • Analgesic 73%
  • Sickle Cell Anemia 71%
  • Non-Steroidal Anti-Inflammatory Agents 70%
  12 Scopus citations

• The FDA Guidance on therapeutic cancer vaccines: The need for revision to include preventive cancer vaccines or for anewguidance dedicated to them

  Finn, O. J., Khleif, S. N. & Herberman, R. B., Nov 2015, In: Cancer Prevention Research. 8, 11, p. 1011-1016 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cancer Vaccines 100%
  • Vaccines 61%
  • Disease Progression 16%
  • Immune System 16%
  • Research Personnel 14%
  7 Scopus citations

• Tumor Lysis Syndrome in Metastatic Colon Cancer Following Treatment with Regorafenib

  Farooqi, B., Simmons, J. & Hao, Z., Oct 1 2015, In: Journal of Gastrointestinal Cancer. 46, 3, p. 314-316 3 p.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations
• 2014

  CYP2C9 allelic variants and frequencies in a pediatric sickle cell disease cohort: Implications for NSAIDs pharmacotherapy

  Jaja, C., Patel, N., Scott, S. A., Gibson, R. & Kutlar, A., Oct 1 2014, In: Clinical and Translational Science. 7, 5, p. 396-401 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytochrome P-450 CYP2C9 100%
  • Nonsteroid Antiinflammatory Agent 86%
  • Sickle Cell Anemia 82%
  • Anti-Inflammatory Agents 55%
  • Pediatrics 48%
  7 Scopus citations

• Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria

  Pantin, J., Tian, X., Geller, N., Ramos, C., Cook, L., Cho, E., Scheinberg, P., Vasu, S., Khuu, H., Stroncek, D., Barrett, J., Young, N. S., Donohue, T. & Childs, R. W., Sep 2014, In: Biology of Blood and Marrow Transplantation. 20, 9, p. 1435-1439 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Paroxysmal Hemoglobinuria 100%
  • fludarabine 91%
  • Cell Transplantation 76%
  • Allogeneic Cells 76%
  • eculizumab 26%
  19 Scopus citations
• 2013

  Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes

  Pantin, J., Tian, X., Shah, A. A., Kurlander, R., Ramos, C., Cook, L., Khuu, H., Stroncek, D., Leitman, S., Barrett, J., Donohue, T., Young, N. S., Geller, N. & Childs, R. W., Oct 2013, In: American Journal of Hematology. 88, 10, p. 874-882 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Bone Marrow Failure Disorders 100%
  • Cell Transplantation 79%
  • Graft vs Host Disease 77%
  • Blood Cells 60%
  • Tissue Donors 57%
  5 Scopus citations

• Recurrent adult choroid plexus carcinoma treated with high-dose chemotherapy and syngeneic stem cell (bone marrow) transplant

  Samuel, T. A., Parikh, J., Sharma, S., Giller, C. A., Sterling, K., Kapoor, S., Pirkle, C. & Jillella, A., Dec 2013, In: Journal of Neurological Surgery, Part A: Central European Neurosurgery. 74, SUPPL.1, p. e149-e154

  Research output: Contribution to journal › Article › peer-review

  • Choroid Plexus Carcinoma 100%
  • Stem Cells 43%
  • Bone Marrow 43%
  • Transplants 37%
  • Drug Therapy 35%
  10 Scopus citations

• Suppression of respiratory papillomatosis with malignant transformation by erlotinib in a kidney transplant recipient

  Hao, Z., Dillard, T., Biddinger, P. & Patel, V., Aug 28 2013, In: BMJ Case Reports. 008757.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Recurrent respiratory papillomatosis 100%
  • Erlotinib Hydrochloride 81%
  • Squamous Cell Neoplasms 80%
  • Cough 61%
  • Transplant Recipients 59%
  2 Scopus citations
• 2009

  Compound heterozygosity for hemoglobin S [β6(A3)Glu6Val] and hemoglobin Korle-Bu [β73(E17)Asp73Asn]

  Akl, P. S., Kutlar, F., Patel, N., Salisbury, C. L., Lane, P. & Young, A. N., Sep 1 2009, In: Laboratory Hematology. 15, 3, p. 20-24 5 p.

  Research output: Contribution to journal › Article › peer-review

  • hemoglobin Korle 100%
  • Sickle Hemoglobin 63%
  • Hemoglobin 41%
  • hemoglobin D Punjab 28%
  • Hemoglobins 24%
  5 Scopus citations
• 2001

  Sanguinarine induces bimodal cell death in K562 but not in high Bcl-2-expressing JM1 cells

  Weerasinghe, P., Hallock, S., Tang, S. C. & Liepins, A., 2001, In: Pathology Research and Practice. 197, 11, p. 717-726 10 p.

  Research output: Contribution to journal › Article › peer-review

  • sanguinarine 100%
  • Blister 63%
  • Cell Death 45%
  • Apoptosis 30%
  • K562 Cells 23%
  31 Scopus citations
• 1999

  Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues

  Yang, X., Hao, Y., Ding, Z., Pater, A. & Tang, S. C., Jul 1999, In: Clinical Cancer Research. 5, 7, p. 1816-1822 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Neoplasms 100%
  • Gene Expression 93%
  • Cell Line 92%
  • Protein Isoforms 84%
  • BCL2-associated athanogene 1 protein 50%
  43 Scopus citations

• Expression of BAG-1 in invasive breast carcinomas

  Tang, S. C., Shaheta, N., Chernenko, G., Khalifa, M. & Wang, X., Jun 1999, In: Journal of Clinical Oncology. 17, 6, p. 1710-1719 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Neoplasms 100%
  • Disease-Free Survival 49%
  • Newfoundland and Labrador 36%
  • Survival 28%
  • Preliminary Data 28%
  74 Scopus citations

• Prolonged severe 5-fluorouracil-associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency

  Shehata, N., Pater, A. & Tang, S. C., 1999, In: Cancer Investigation. 17, 3, p. 201-205 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Dihydropyrimidine Dehydrogenase Deficiency 100%
  • Fluorouracil 54%
  • Dihydrouracil Dehydrogenase (NADP) 53%
  • Nervous System 23%
  • Dermatitis 15%
  33 Scopus citations